In terms of immunohistochemistry, expression of CD20 in lymphoma tissue could be detected in all patients, while only 32% (18/56) expressed CD10, 74% (34/46) Bcl-6, 65% (17/26) Bcl-2, and 66% (35/53) MUM1. This evidence concerns the gene BCL6 and lymphoma.